bryan johnson bpc 157 CJC-1295 Peptide Experiment: Adverse Effects and Results Well said. While Bryan Johnson’s

Its unusual (and concerning) for a completed Phase I not to report anything, but no official reason was given

BPC-157 is supplied by NuRev Peptides strictly for laboratory research and testing purposes

However, preservative systems are only one component of contamination control

Results Results were visible in several brain areas, including the substantia nigra of the midbrain and the medial anterior olfactory nucleus, with a simultaneous decrease in the hypothalamus, ventral and dorsal hippocampus, and dorsal thalamus

588 Boosting NAD + as a therapeutic strategy In general, intracellular NAD + levels are maintained between 0.2 and 0.5 mM, depending on the cell type or tissue